FORT WORTH, Texas — Alcon’s ReStor multifocal IOL showed no difference in contrast sensitivity results from monofocal lenses, according to results of a multicenter trial. Almost 75% of patients ...
SALT LAKE CITY, UT--(Marketwired - Jun 14, 2017) - In March 2017, the U.S. Food and Drug Administration approved a new, advanced intraocular lens implant (IOL) called the Acrysof IQ ReSTOR® +2.5 ...
The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses The ...
Bossier City, La.-based Zaffater Eye Center’s Norman Zaffater, MD, became the first physician in the Shreveport-Bossier area to implant the ReSTOR Multifocal TORIC intraocular lens, according to the ...
(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...
In a near-unanimous vote, a US Food and Drug Administration (FDA) device panel endorsed Alcon Research, Ltd's AcrySof IQ ReSTOR multifocal toric posterior chamber intraocular lens (IOL). The proposed ...
LONDON – Refractive lens exchange combined with LASIK can extend the indications for using a multifocal IOL to include patients with astigmatism, one surgeon told an audience at the European Society ...
April 15, 2005 — The U.S. Food and Drug Administration (FDA) has approved a rechargeable neurostimulation system to aid in the management of chronic intractable pain of the trunk and/or limbs; a dural ...
Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback